13F filing recap · Q3 2025
What did Polen Capital Management buy in Q3 2025?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every Polen account, including accounts that belong to no fund below.
Stock value
$30.80B
Positions
232
Estimated turnover
39.4%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Polen Capital Management opened new positions in Broadcom, Boston Scientific, Synopsys, and Intuit, among many smaller additions. The firm exited Aaon, Adma Biologics, Alkami Technology, Allison Transmission, and numerous other holdings. It trimmed Oracle, Amazon, Shopify, and Visa, while slightly reducing Microsoft, Mastercard, and Eli Lilly. Nvidia was sharply increased.